Article
Oncology
Eric M. Anderson, Michael Luu, Diana J. Lu, Eric M. Chung, Mitchell Kamrava
Summary: This study aimed to investigate the risk factors for lymph node involvement in patients with less common histologies of endometrial cancer. The study found that predictors of lymph node positivity in non-endometrioid endometrial cancer patients are similar to endometrial adenocarcinoma, which could be helpful in making adjuvant treatment decisions for these less common histologies.
GYNECOLOGIC ONCOLOGY
(2022)
Article
Biology
Eric M. Anderson, Michael Luu, Mitchell Kamrava
Summary: The presence of lymph node involvement in endometrial cancer patients guides treatment decisions. This study used a database of patients diagnosed between 2004 and 2016 to identify predictors of lymph node involvement. In addition to tumor characteristics, patient age and race were found to be associated with a higher risk of lymph node involvement.
Article
Obstetrics & Gynecology
Serhat Toprak, Eda Adeviye Sahin, Hanifi Sahin, Yusuf Aytac Tohma, Ercan Yilmaz, Mehmet Mutlu Meydanli
Summary: Lymphovascular space invasion, primary tumor diameter of at least 3 cm, and at least 50% deep myometrial invasion are independent predictors of cervical stromal involvement in patients with endometrioid-type endometrial cancer.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
(2021)
Article
Oncology
Fengxiang Zhang, Huaxian Chen, Dandong Luo, Zhizhong Xiong, Xianzhe Li, Shi Yin, Longyang Jin, Shi Chen, Junsheng Peng, Lei Lian
Summary: Lymphovascular invasion (LVI) and perineural invasion (PNI) are associated with poorer prognosis in gastric cancer (GC). This study aimed to investigate their prognostic value in curative resected GC patients. The incidence of LVI/PNI was significantly higher in GC patients compared to colorectal cancer patients (50.54% vs. 21.91%, p < 0.001). LVI/PNI was closely associated with disease progression and served as an independent risk factor for lymph node metastasis and overall survival in GC.
Review
Oncology
Xiaoying Jin, Chunjuan Shen, Xiaodi Yang, Yayuan Yu, Jianzhang Wang, Xuan Che
Summary: This study conducted a meta-analysis and found that primary tumor size > 20 mm was significantly associated with depth of MI, positive LVSI, positive LNM, recurrence, and poor OS. Therefore, considering the value of tumor size is crucial in the clinicopathological staging of endometrial carcinoma, and tumor size > 20 mm should be integrated into the intraoperative algorithm for performing a full surgical staging.
FRONTIERS IN ONCOLOGY
(2022)
Article
Medicine, General & Internal
Xi-Lin Yang, Nan Huang, Ming-Ming Wang, Hua Lai, Da-Jun Wu
Summary: Comparing the prognostic predictive performance of six lymph node staging schemes in node-positive endometrioid endometrial cancer patients, it was found that lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS) had better predictive performance for prognosis assessment than other number-based lymph node schemes, suggesting that LNR and LODDS may be more useful in prognosis assessment for these patients than the AJCC N stage.
FRONTIERS IN MEDICINE
(2021)
Article
Oncology
Caressa Hui, Maria G. Mendoza, Rie von Eyben, Oliver Dorigo, Babak Litkouhi, Malte Renz, Amer Karam, Phoebe M. Hammer, Brooke E. Howitt, Elizabeth Kidd
Summary: Despite lymph node assessment, patients with high-intermediate risk early-stage or stage IIIC endometrial cancer who have abnormal p53 expression and/or substantial lymphovascular space invasion (LVSI) have poorer outcomes. Intensification with external beam radiation therapy (EBRT) may benefit these patients by improving local and pelvic control.
GYNECOLOGIC ONCOLOGY
(2023)
Review
Medicine, General & Internal
Hans Nagar, Nina Wietek, Richard J. Goodall, Will Hughes, Mia Schmidt-Hansen, Jo Morrison
Summary: Pelvic lymphadenectomy provides prognostic information for endometrial cancer patients, but has not shown therapeutic benefits and causes significant morbidity. Sentinel lymph node biopsy (SLNB) has high diagnostic accuracy in detecting pelvic lymph node involvement in early stage endometrial cancer, with different tracers affecting detection rates. Further research is needed to evaluate the value of SLNB in treatment pathways and to conduct high-quality intervention studies.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
(2021)
Article
Oncology
Gaoyan Yao, Yi Fang, Yangbo Fu, Jinghong Xu, Haojun Song, Hangqin Zhu, Mengli Gu, Xiaoyun Ding
Summary: Tumor budding is associated with tumor size, tumor histologic differentiation, depth of invasion, lymph node metastasis, lympho-vascular invasion, and early recurrence of early gastric cancer. High-grade tumor budding, especially, can predict lymph node metastasis in early gastric cancer and may be an important parameter for evaluating the prognosis of patients with early gastric cancer.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Obstetrics & Gynecology
Serkan Akis, Canan Kabaca, Esra Keles, Ugur Kemal Ozturk, Eser Ozyurek, Murat Api, Handan Cetiner, Evrim Bostanci
Summary: The study identified tumor diameter as an independent predictor for lymphatic dissemination, with a 10 mm increase in diameter increasing the risk of lymph node involvement tenfold. This finding could potentially lead to a reevaluation of the need for lymphadenectomy or adjuvant radiotherapy based on tumor diameter models in the future.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
(2021)
Article
Oncology
Tomo Sato, Yoshihisa Shimada, Takahiro Mimae, Yasuhiro Tsutani, Yoshihiro Miyata, Hiroyuki Ito, Haruhiko Nakayama, Morihito Okada, Norihiko Ikeda
Summary: The study revealed that pN and Ly statuses were independent prognostic factors in patients with clinically N0 stage I-III NSCLC, while diseases presenting with pN + with Ly + were associated with increased rates of distant and lymph node recurrence.
Article
Oncology
Baki Erdem, Ibrahim Celebi, Osman Asicioglu, Sedat Akgol, Ilkbal Temel Yuksel, Ipek Yildiz Ozaydin, Fitnat Topbas, Ozgur Akbayir
Summary: In surgically treated CC patients, tumor diameter >= 30 mm and LVSI (+) on diagnostic biopsy were found to be independent risk factors for LNM. This study provides important guidance for the treatment selection in CC.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
(2022)
Article
Oncology
Weitao Zhuang, Hansheng Wu, Rixin Chen, Xiaosong Ben, Shujie Huang, Zihao Zhou, Junhan Wu, Yong Tang, Guibin Qiao
Summary: This study analyzed the staging value of lymphovascular invasion (LVI) in esophageal squamous cell carcinoma (ESCC). The results showed that LVI is an independent prognostic factor for clinical-pathological relevance and prognosis in ESCC patients, and can further improve the predictive accuracy of staging models.
FRONTIERS IN ONCOLOGY
(2022)
Review
Oncology
Jianzhang Wang, Ping Xu, Xueying Yang, Qin Yu, Xinxin Xu, Gen Zou, Xinmei Zhang
Summary: This meta-analysis study found that deep myometrial invasion is positively associated with lymphovascular space invasion, lymph node metastasis, cancer recurrence, and overall survival in endometrial cancer patients. It suggests that myometrial invasion can be a useful evaluation criterion for clinical outcomes and prognosis of endometrial cancer, highlighting the importance of paying attention to myometrial invasion in clinical practice. Further investigation into the underlying mechanisms is warranted.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Vanessa M. Lopez-Ozuna, Liron Kogan, Mahmood Y. Hachim, Emad Matanes, Ibrahim Y. Hachim, Cristina Mitric, Lauren Liu Chen Kiow, Susie Lau, Shannon Salvador, Amber Yasmeen, Walter H. Gotlieb
Summary: Obesity is a known risk factor for endometrial cancer and is associated with increased risks of intraoperative and postoperative complications. A novel panel of genes has been discovered that can predict lymph node involvement in obese patients with endometrial cancer.
FRONTIERS IN ONCOLOGY
(2021)